| Taxotere Approved for Head and Neck Cancer (HealthDay) - in yahoo news - HealthDay - WEDNESDAY, Oct. 18 (HealthDay News) -- Taxotere (docetaxel) has received expanded approval to treat cancer of the head and neck, which accounts for about 3 percent of all cancer cases in the United States, the U.S. Food and Drug Administration... |